-
Combined Detection of Tumor Stem Cell Markers CD133 and OCT4 in Early Non-Small Cell Lung Cancer Screening and Prognostic Evaluation
19 Sep 2025 04:26 GMT
… CSC maintenance within lung cancer regulatory networks.
Previous … Gefitinib on A549 non-small cell lung cancer cells … disease combined with lung cancer: current understanding and … lung cancer assessed by multiplex immunofluorescence. Transl Lung Cancer Res …
-
FLAURA2 phase III trial of AstraZeneca's Tagrisso plus chemotherapy demonstrated a median overall survival in EGFR─mutated advanced lung cancer
09 Sep 2025 10:38 GMT
… EGFRm) non-small cell lung cancer (NSCLC).
These results … . Lung cancer is broadly split into small cell lung cancer or … including Tagrisso and Iressa (gefitinib); Imfinzi (durvalumab) and Imjudo … improvements for people with lung cancer, including and beyond …
-
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer
06 Sep 2025 09:08 GMT
… Study of Lung Cancer (IASLC) 2025 World Congress on Lung Cancer (WCLC … Non-Small Cell Lung Cancer
Worldwide, lung cancer is one of … and molecular characteristics of lung cancers harboring EGFR exon … et al. Lazertinib versus gefitinib as first-line treatment …
-
I'm 80 and never smoked but my sore shoulder was actually sign of terminal lung cancer
22 Aug 2025 03:47 GMT
… smoked - but doctors explained lung cancer isn't just … )
Mavis now takes a Gefitinib tablet once a day - … effective way to manage her lung cancer. Although she has endured … NHS Guidance on Lung Cancer You can still develop lung cancer, even if you …
-
Lung Cancer In Women: Why The Symptoms Are Often Missed Or Misdiagnosed
03 Aug 2025 09:58 GMT
… female lung cancer patients were non-smokers, suggesting that lung cancer … inhibitors (e.g., gefitinib or erlotinib), which can … at diagnosis to tailor lung cancer treatment.
Frequently observed symptoms … must emphasize that lung cancer affects women without …
-
Differential Responses to Targeted Therapies in Non-Small Cell Lung Cancer: A Comparative Analysis of Outcomes in Patients with Single EGFR Mutation and Concurrent Gene Alterations
31 Jul 2025 12:56 GMT
… advanced-stage EGFR-mutant lung cancers. Nat Genet. 2017 … pathway: potential for lung cancer treatment. Lung Cancer Manag. 2014;3 … status in Japanese lung cancer patients. Lung Cancer. 2006;54(2 … leads to gefitinib resistance in lung cancer by activating ERBB3 …
-
AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR─mutated advanced lung cancer
22 Jul 2025 04:57 GMT
… therapy in EGFR-mutated lung cancer, demonstrating that Tagrisso … 1 Lung cancer is broadly split into small cell lung cancer … including Tagrisso and Iressa (gefitinib); Imfinzi (durvalumab) and … improvements for people with lung cancer, including and beyond …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… with drugs such as gefitinib, marked a significant milestone … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. … non-small cell lung cancer patients. Lung Cancer. 2011;72(2 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer. …
-
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
24 Jun 2025 11:26 GMT
… small cell lung cancer
Nearly 2.5 million lung cancer cases … including TAGRISSO and IRESSA (gefitinib); IMFINZI and IMJUDO; ENHERTU … in non-small cell lung cancer. Translational Lung Cancer Research. 2015;4 … TROP2 in non-small lung cancers and its correlation …
-
MHRA approves SFL’s Aumseqa to treat EGFR-mutated lung cancer in adults
09 Jun 2025 11:29 GMT
… subset of non-small cell lung cancer (NSCLC) patients.
The oral drug … ,000 people are diagnosed with lung cancer every year in the UK … to slow or stop the lung cancer from growing, as well reduce … death by 54% compared to gefitinib, an approved cancer drug, in …